| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Jun―01 |
Long COVID-19 “A Metabolic Sequela,” the New-Onset Diabetes among Cohorts Admitted at Tertiary Care Hospital, Hyderabad |
Sudha Bala, Surendra B Darivemula, Shrikanth Muralidharan, Rajiv K Bandaru, Sushma N Katkuri, Anesha Singireddy |
| 2 |
[GO] |
2024―Jun―01 |
The Impact of Insulin Degludec on Glucocorticoid-Induced Hyperglycemia in Patients with Diabetes and COVID-19 Infection |
Varun Prasanna, Ravindranath Venketesan |
| 3 |
[GO] |
2024―Jun―01 |
Management of Type 1 Diabetes in Children During the COVID-19 Pandemic in Turkey: Before, During, and After the Lockdown Period |
Seda Çağlar, Gamze Kaş Alay, Dilek Sönmez Sağlık, Huriye Karadede |
| 4 |
[GO] |
2024―Mrz―18 |
Procalcitonin and D-dimer as a prognostic marker and outcome predictor in COVID-19 patients and effect of comorbidities on these biomarkers |
Tej P Singh, Upendra N Gupta, Jitendra Doneriya, Pravesh Chaudhary, Manish K Singh, Ishan Chaturvedi, Anubhav S Pawar |
| 5 |
[GO] |
2023―Mai―31 |
Papular lesions in a diabetic patient with COVID-19: A case report from India |
Ashish S Dengra, Jigyasa Dengra, Faraz Farishta, Ramchandani GD |
| 6 |
[GO] |
2023―Mrz―17 |
Strategies adopted in conduct of clinical trials amidst coronavirus disease-2019 (COVID-19) |
Subramani Poongothai, RanjitMohan Anjana, Ramasamy Aarthy, Selvam Kasthuri, MohamedAlthab Begum, Kulasegaran Karkuzhali, et al. (+8) Kannikan Viswanathan, Balasundaram Bhavani Sundari, Ravi Pavitha, Boopathi Hemalatha, AbdulAli Tameem Nisha, Mahalakshmi Ravisankar, Rajkumar Marappan, Jagannathan Ramesh |
| 7 |
[GO] |
2023―Mrz―17 |
Vitamin D and its role in coronavirus disease 2019 (COVID-19) |
VirajRamesh Suvarna, Viswanathan Mohan |
| 8 |
[GO] |
2023―Mrz―17 |
Diabetes and coronavirus disease-2019 (COVID-19) |
Ranjit Unnikrishnan, Banshi Saboo, Jothydev Kesavadev, Neeta Deshpande, SosaleRamachandra Aravind, Shashank Joshi, et al. (+3) RanjitMohan Anjana, Akhtar Hussain, Viswanathan Mohan |
| 9 |
[GO] |
2023―Mrz―17 |
Coronavirus disease-2019 (COVID-19) and its effect on diabetes |
Viswanathan Mohan |
| 10 |
[GO] |
2023―Mrz―17 |
Knowledge of COVID-19 and perception regarding isolation, quarantine, social distancing, and community containment during COVID-19 pandemic among people with diabetes |
Asher Fawwad, Nida Mustafa, Nazish Waris, Saima Askari, Abdul Basit |
| 11 |
[GO] |
2023―Mrz―17 |
COVID-19, hypertension, and cardiovascular disease |
CVenkata S Ram, HK Chopra, RR Kasliwal, A Muruganathan, Mohsin Wali |
| 12 |
[GO] |
2023―Mrz―17 |
Impact of glycemic control in diabetes mellitus on management of COVID-19 infection |
Govind Rankawat, Sudhir Bhandari, Ajeet Singh, Vishal Gupta, Shivankan Kakkar |
| 13 |
[GO] |
2023―Mrz―17 |
Subclinical COVID-19 infection in Indian children with new-onset type 1 diabetes |
SanketS Pendsey, SharadP Pendsey, SeemaS Chalkhore |
| 14 |
[GO] |
2023―Mrz―17 |
Use of telemedicine for the management of type 1 diabetes in children and adolescents in Bangladesh during the COVID-19 pandemic |
Bedowra Zabeen, Bishwajit Bhowmik, Kamrul Huda, Farzana Naz, Samin Tayyeb, Kishwar Azad |
| 15 |
[GO] |
2023―Mrz―17 |
Survey of diabetologists and obstetricians’ practice patterns related to care for gestational diabetes mellitus during the COVID-19 pandemic in India |
Balaji Bhavadharini, Ram Uma, RanjitM Anjana, Viswanathan Mohan |
| 16 |
[GO] |
2023―Mrz―17 |
Is diabetes a real challenge in COVID-19 patients? |
MuhammedJasim Abdul Jalal |
| 17 |
[GO] |
2023―Mrz―17 |
The role of hydroxychloroquine in COVID-19: Where do we stand? |
RanjitMohan Anjana, NadimintyGanapathi Sastry, Muthu Ramuu, PrasannaKumar Gupta, Jaggi Shalini, BrijendraKumar Srivastava, et al. (+7) ChaithanyaMurthy Kocherlakota, TataSameer Nandan, Gangadhara Praveen, Jyotish Nair, Routray Philips, Viswanathan Mohan, Ranjit Unnikrishnan |
| 18 |
[GO] |
2023―Feb―18 |
Development and validation of a situational anxiety scale screening assessment among adults with type 2 diabetes during COVID-19 at a tertiary centre in Chennai, India |
Subramani Poongothai, Satish Latha, Mokkapati Lalasa, Karthikeyan Swetha, Viswanathan Mohan |
| 19 |
[GO] |
2023―Feb―18 |
Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patients |
Elif Torun Parmaksız, Ergün Parmaksız |
| 20 |
[GO] |
2022―Dez―21 |
A systematic review approach in understanding the COVID-19 mechanism in diabetes and its progression to diabetic microvascular complications |
GyanendraKumar Sonkar, Sangeeta Singh, SatyendraKumar Sonkar |
| 21 |
[GO] |
2022―Aug―26 |
A study on the health and socioeconomic impact of COVID-19 pandemic and barriers to self-management of diabetes during the lockdown among rural residents of South India |
Rajendra Pradeepa, Natarajan Lakshmi, RanjitMohan Anjana, Moneeza Siddiqui, Sait Sonie, EwanR Pearson, et al. (+3) Alexander Doney, ColinN A Palmer, Viswanathan Mohan |
| 22 |
[GO] |
2022―Apr―05 |
Living with type 2 diabetes in COVID-19: Correspondence |
Pathum Sookaromdee, Viroj Wiwanitkit |
| 23 |
[GO] |
2021―Sep―30 |
Diabetes: The set stage for mucormycosis post COVID-19 |
TarunKumar Suvvari, Nithya Arigapudi, NagaAlekhya Garikipati, SriHarsha Boppana |
| 24 |
[GO] |
2021―Sep―30 |
Impact of COVID-19 on noncommunicable diseases (NCDs) |
ManojArajanbhai Suva, VirajRamesh Suvarna, Viswanathan Mohan |
| 25 |
[GO] |
2021―Sep―30 |
Bibliometric analysis of diabetes research in relation to the COVID-19 pandemic |
Devi Dayal, BrijMohan Gupta, Rimesh Pal, Latika Rohilla |
| 26 |
[GO] |
2021―Sep―30 |
Living with type 2 diabetes in COVID-19: Exploring the challenges faced |
Neha Agarwal, Rishi Shukla, Manisha Gupta, MandaraMuralidhar Harikar, Anurag Bajpai |
| 27 |
[GO] |
2021―Sep―30 |
Angiotensin converting enzyme (ACE)-2: Beyond just the entry point for the SARS-CoV-2: A commentary |
Viraj Suvarna, Shashank Joshi |
| 28 |
[GO] |
2021―Mrz―30 |
Psychological impact of COVID-19 on teens belonging to a social media group |
K Geethika Sai, Ramesh Jalaja, Anandakumar Amutha, U Venkatesan, RanjitMohan Anjana, Ranjit Unnikrishnan |
| 29 |
[GO] |
2020―Aug―31 |
Guide on diabetes and COVID-19 for healthcare professionals in Bangladesh |
Bishwajit Bhowmik, Tareen Ahmed, Faria Afsana, NazmulKabir Qureshi, Tasnima Siddiquee, Faruque Pathan, et al. (+24) Firoz Amin, NaylaCristina do Vale Moreira, MA Samad, SM Ashrafuzzaman, Tofail Ahmed, ZafarAhmed Latif, AbulMajid Bhuiyan, Abdul Alim, SanjidaBinte Munir, RajatKanti Karmokar, KaiserAlam Choudhury, Bedowra Zabeen, Khaleda Islam, MohammadMahbubur Rahman, Mofizur Rahman, SarowarUddin Milon, Rie Ozaki, Md. AbdurRazzaqul Alam, Tabassum Huda, Md. Habibur Rahman, AHMEnayet Hossain, Hajera Mahtab, Akhtar Hussain, AKAzad Khan |
| 30 |
[GO] |
2020―Aug―31 |
Management of coronavirus disease-2019 (COVID-19) in patients with diabetes |
Dhanasekaran Bodhini, Viswanathan Mohan |
| 31 |
[GO] |
2020―Aug―31 |
COVID-19: Considerations for children and adolescents with diabetes |
Devi Dayal, Arti Yadav |
| 32 |
[GO] |
2020―Aug―31 |
Dipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option |
AwadheshKumar Singh, Ritu Singh |
| 33 |
[GO] |
2020―Aug―31 |
Telemedicine for the initial management of newly diagnosed gestational diabetes in the pandemic period: A report of three case studies |
AmbikaGopalakrishnan Unnikrishnan, MonieRiju Simon, Nikita Sarkar, Suganthi Kumaran, Anil Chittake, Vedavati Purandare |
